APA (7th ed.) Citation

P, T., D, L., J, F., PR, S., CP, G., T, G., . . . S, S. (2025). Outcomes with trastuzumab deruxtecan by biomarker status, line of treatment and prior receipt of sacituzumab govitecan in a large real-world database of patients with metastatic breast cancer. ESMO open, 10(7), 105330. https://doi.org/10.1016/j.esmoop.2025.105330

Chicago Style (17th ed.) Citation

P, Tarantino, et al. "Outcomes with Trastuzumab Deruxtecan by Biomarker Status, Line of Treatment and Prior Receipt of Sacituzumab Govitecan in a Large Real-world Database of Patients with Metastatic Breast Cancer." ESMO Open 10, no. 7 (2025): 105330. https://doi.org/10.1016/j.esmoop.2025.105330.

MLA (9th ed.) Citation

P, Tarantino, et al. "Outcomes with Trastuzumab Deruxtecan by Biomarker Status, Line of Treatment and Prior Receipt of Sacituzumab Govitecan in a Large Real-world Database of Patients with Metastatic Breast Cancer." ESMO Open, vol. 10, no. 7, 2025, p. 105330, https://doi.org/10.1016/j.esmoop.2025.105330.